Vancomycin-induced acute generalised exanthematous pustulosis.

Area of Science:

• Dermatology
• Pharmacology
• Internal Medicine

Background:

• Antibiotics are known to cause various dermatological adverse reactions.
• Distinguishing between different drug-induced rashes can be challenging.
• Acute generalised exanthematous pustulosis (AGEP) is a specific type of drug eruption.

Purpose of the Study:

• To report a case of AGEP following vancomycin treatment.
• To highlight the importance of recognizing and differentiating drug-induced dermatological conditions.

Main Methods:

• A case study of a female patient in her 30s.
• Clinical observation of dermatological adverse reactions post-vancomycin therapy.
• Documentation of patient's response to supportive care.

Main Results:

• The patient developed acute generalised exanthematous pustulosis after receiving vancomycin for cellulitis.
• Discontinuation of vancomycin and supportive care led to rash improvement.
• The case illustrates a distinct dermatological presentation of a drug reaction.

Conclusions:

• Vancomycin can induce acute generalised exanthematous pustulosis.
• Prompt identification and management of drug reactions are crucial for patient care.
• Differentiating AGEP from other rashes ensures appropriate supportive treatment is initiated.